- ¥14bn
- ¥14bn
- ¥7bn
- 96
- 47
- 51
- 76
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,789 | 5,796 | 4,548 | 5,365 | 6,529 |
Cost of Revenue | |||||
Gross Profit | 2,145 | 3,610 | 2,804 | 3,321 | 4,350 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,329 | 4,812 | 4,021 | 4,529 | 5,697 |
Operating Profit | 459 | 984 | 527 | 836 | 832 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 458 | 983 | 537 | 837 | 837 |
Provision for Income Taxes | |||||
Net Income After Taxes | 334 | 652 | 368 | 582 | 586 |
Net Income Before Extraordinary Items | |||||
Net Income | 334 | 652 | 368 | 582 | 586 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 334 | 652 | 368 | 582 | 586 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 39.5 | 77.4 | 43.7 | 57.6 | 60.2 |
Dividends per Share | |||||
Special Dividends per Share |